TFLL Pharma Belgium SRL
TFLL Pharma Belgium reported total assets of 13,880 € at the end of the 2024 financial year (annual accounts filed with the NBB on 02 Oct 2025).
The score of TFLL Pharma Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TFLL Pharma Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 02 Oct 2025
- Year ended 31 Dec 2023filed on 16 Sep 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
- Year ended 31 Dec 2020filed on 20 Jul 2021
TFLL Pharma Belgium's financial analysis
- Solvency-831.1%sector median: 60.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TFLL Pharma Belgium
TFLL Pharma Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.626.027
- VAT number
- BE0681626027
- Peppol
- Registered · 0208:0681626027 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Sep 2017
- Registered office
- 3590 Diepenbeek
- Latest accounts
- 2024 · filed on 02 Oct 2025
- Activity
- Market research and public opinion polling (NACE 73200)
TFLL Pharma Belgium (SRL) has been based in Diepenbeek since 2017, active in: market research and public opinion polling. For 2024, it reports a net loss of 25,000 € and equity of −115,358 €; its revenue is not published. Its solvency stands at -831.1%, below the median of its sector (60.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to TFLL Pharma Belgium
Companies in the same business, of comparable size and area, outside its group.
- Silex Marketing Market research and public opinion polling Charleroi · balance sheet 13,919 €
- Stripes Market research and public opinion polling Ottignies-Louvain-la-Neuve · balance sheet 13,607 €
- OneMarket Market research and public opinion polling Auderghem · balance sheet 13,081 €
- Gillet Capron Diffusion Market research and public opinion polling Woluwe-Saint-Pierre · balance sheet 12,195 €
- Euro TEC Trading - Engineering - Consulting Market research and public opinion polling Brussels · balance sheet 9,930 €
- APCO Projects Market research and public opinion polling Tremelo · balance sheet 11,621 €
- Tournel Projects Market research and public opinion polling Alken · balance sheet 11,600 €
- Lancaster Consult Market research and public opinion polling Rebecq · balance sheet 11,098 €
Frequently asked questions about TFLL Pharma Belgium
What is the revenue of TFLL Pharma Belgium?
TFLL Pharma Belgium files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of TFLL Pharma Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0681626027 for TFLL Pharma Belgium, if the company is VAT-registered. Its company number (CBE) is 0681.626.027.
Where is the registered office of TFLL Pharma Belgium?
According to the CBE register, the registered office of TFLL Pharma Belgium is in 3590 Diepenbeek.
What is the equity of TFLL Pharma Belgium?
At the close of the 2024 financial year, the equity of TFLL Pharma Belgium amounts to -115,358 €, a solvency of -831.1% of total assets.
Who manages TFLL Pharma Belgium?
The register lists 1 active mandates at TFLL Pharma Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TFLL Pharma Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →